Reviews, Commentaries, Profiles and Hypothesis Articles - FREE TO ALL

Full text files of all Review Articles, Commentaries, Profiles and Hypothesis Articles published in Society for Endocrinology journals (Endocrine-Related Cancer, Journal of Molecular Endocrinology and Journal of Endocrinology) are freely available to all. Sign-up for Table of Contents alerts to receive notification of new articles.

Details are listed below.

FREE ARCHIVE 2014

  • REVIEW: Alex Rafacho, Henrik Ortsäter, Angel Nadal, and Ivan Quesada
  • Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes
  • Journal of Endocrinology 223 R49–R62 (December 2014)
  • REVIEW: Ivana Vaněčková, Lenka Maletínská, Michal Behuliak, Veronika Nagelová, Josef Zicha, and Jaroslav Kuneš
  • Obesity-related hypertension: possible pathophysiological mechanisms
  • Journal of Endocrinology 223 R63–R78 (December 2014)
  • REVIEW: Mark A Exley, Laura Hand, Donal O'Shea, and Lydia Lynch
  • Interplay between the immune system and adipose tissue in obesity
  • Journal of Endocrinology 223 R41–R48 (November 2014)
  • REVIEW: Daniel Cuevas-Ramos and Maria Fleseriu
  • Treatment of Cushing's disease: a mechanistic update
  • Journal of Endocrinology 223 R19–R39 (November 2014)
  • REVIEW: Claire V Hutchinson, James A Walker, and Colin Davidson
  • Oestrogen, ocular function and low-level vision: a review
  • Journal of Endocrinology 223 R9–R18 (November 2014)
  • THEMATIC REVIEW: Mark E Peterson
  • ANIMAL MODELS OF DISEASE: Feline hyperthyroidism: an animal model for toxic nodular goiter
  • Journal of Endocrinology 223 T97–T114 (November 2014)
  • REVIEW: Dimitri Novitzky and David K C Cooper
  • Thyroid hormone and the stunned myocardium
  • Journal of Endocrinology 223 R1–R8 (October 2014)
  • THEMATIC REVIEW: Michael Rosenbaum and Rudolph L Leibel
  • 20 YEARS OF LEPTIN: Role of leptin in energy homeostasis in humans
  • Journal of Endocrinology 223 T83–T96 (October 2014)
  • THEMATIC REVIEW: Alex M DePaoli
  • 20 YEARS OF LEPTIN: Leptin in common obesity and associated disorders of metabolism
  • Journal of Endocrinology 223 T71–T71 (October 2014)
  • THEMATIC REVIEW: I Sadaf Farooqi and Stephen O'Rahilly
  • 20 YEARS OF LEPTIN: Human disorders of leptin action
  • Journal of Endocrinology 223 T63–T70 (October 2014)
  • THEMATIC REVIEW: Sharon H Chou and Christos Mantzoros
  • 20 YEARS OF LEPTIN: Role of leptin in human reproductive disorders
  • Journal of Endocrinology 223 T49–T62 (October 2014)
  • THEMATIC REVIEW: Farid F Chehab
  • 20 YEARS OF LEPTIN: Leptin and reproduction: past milestones, present undertakings, and future endeavors
  • Journal of Endocrinology 223 T37–T48 (October 2014)
  • THEMATIC REVIEW: Margaret B Allison and Martin G Myers, Jr
  • 20 YEARS OF LEPTIN: Connecting leptin signaling to biological function
  • Journal of Endocrinology 223 T25–T35 (October 2014)
  • THEMATIC REVIEW: Frank Peelman, Lennart Zabeau, Kedar Moharana, Savvas N Savvides, and Jan Tavernier
  • 20 YEARS OF LEPTIN: Insights into signaling assemblies of the leptin receptor
  • Journal of Endocrinology 223 T9–T23 (October 2014)
  • THEMATIC REVIEW: Jeffrey Friedman
  • 20 YEARS OF LEPTIN: Leptin at 20: an overview
  • Journal of Endocrinology 223 T1–T8 (October 2014)
  • EDITORIAL: Steve O'Rahilly
  • 20 YEARS OF LEPTIN: What we know and what the future holds
  • Journal of Endocrinology 223 E1–E3 (October 2014)
  • REVIEW: Hen Prizant, Norbert Gleicher, and Aritro Sen
  • Androgen actions in the ovary: balance is key
  • Journal of Endocrinology 222 R141–R151 (September 2014)
  • REVIEW: Mina Elahy, Swati Baindur-Hudson, Vinicius F Cruzat, Philip Newsholme, and Crispin R Dass
  • Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy
  • Journal of Endocrinology 222 R129–R139 (September 2014)
  • REVIEW: Milos Mraz and Martin Haluzik
  • The role of adipose tissue immune cells in obesity and low-grade inflammation
  • Journal of Endocrinology 222 R113–R127 (September 2014)
  • REVIEW: Aowen Zhuang and Josephine M Forbes
  • Stress in the kidney is the road to pERdition: is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy?
  • Journal of Endocrinology 222 R97–R111 (September 2014)
  • THEMATIC REVIEW: Richard W Nelson and Claudia E Reusch
  • ANIMAL MODELS OF DISEASE: Classification and etiology of diabetes in dogs and cats
  • Journal of Endocrinology 222 T1–T9 (September 2014)
  • SCIENCE GUIDELINE: James E Bowe, Zara J Franklin, Astrid C Hauge-Evans, Aileen J King, Shanta J Persaud, and Peter M Jones
  • METABOLIC PHENOTYPING GUIDELINES: Assessing glucose homeostasis in rodent models
  • Journal of Endocrinology 222 G13–G25 (September 2014)
  • REVIEW: Shannon M Bailey, Uduak S Udoh, and Martin E Young
  • Circadian regulation of metabolism
  • Journal of Endocrinology 222 R75–R96 (August 2014)
  • REVIEW: Ynuk Bossé
  • Endocrine regulation of airway contractility is overlooked
  • Journal of Endocrinology 222 R61–R73 (July 2014)
  • REVIEW: Shona Wood and Andrew Loudon
  • Clocks for all seasons: unwinding the roles and mechanisms of circadian and interval timers in the hypothalamus and pituitary
  • Journal of Endocrinology 222 R39–R59 (August 2014)
  • SCIENCE GUIDELINE: Catherine Gibbons, Graham Finlayson, Michelle Dalton, Phillipa Caudwell, and John E Blundell
  • METABOLIC PHENOTYPING GUIDELINES: Studying eating behaviour in humans
  • Journal of Endocrinology 222 G1–G12 (August 2014)
  • REVIEW: Manuela Elsen, Silja Raschke, and Jürgen Eckel
  • Browning of white fat: does irisin play a role in humans?
  • Journal of Endocrinology 222 R25–R38 (July 2014)
  • REVIEW: Syed Jalal Khundmiri
  • Advances in understanding the role of cardiac glycosides in control of sodium transport in renal tubules
  • Journal of Endocrinology 222 R11–R24 (July 2014)
  • REVIEW: Haiyong Chen, Hui-Yao Lan, Dimitrios H Roukos, and William C Cho
  • Application of microRNAs in diabetes mellitus
  • Journal of Endocrinology 222 R1–R10 (July 2014)
  • REVIEW: Su Liu, Shin-Jen Lin, Gonghui Li, Eungseok Kim, Yei-Tsung Chen, Dong-Rong Yang, M H Eileen Tan, Eu Leong Yong, and Chawnshang Chang
  • Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases
  • Endocrine-Related Cancer 21 R279–R300 (June 2014)
  • REVIEW: Ales Vicha, David Taieb, and Karel Pacak
  • Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma
  • Endocrine-Related Cancer 21 R261–R277 (June 2014)
  • REVIEW: José O Alemán, Azeez Farooki, and Monica Girotra
  • Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies
  • Endocrine-Related Cancer 21 R247–R259 (June 2014)
  • REVIEW: V Craig Jordan
  • Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer
  • Endocrine-Related Cancer 21 R235–R246 (June 2014)
  • REVIEW: Raymond R Y Wong, Michael J Worley, Jr, Tony K H Chung, and Yick Fu Wong
  • An update on Müllerian-inhibiting substance: its potential application against ovarian cancere
  • Endocrine-Related Cancer 21 R227–R233 (June 2014)
  • REVIEW: Lindsay G Carter, John A D'Orazio, and Kevin J Pearson
  • Resveratrol and cancer: focus on in vivo evidence
  • Endocrine-Related Cancer 21R209–R225 (June 2014)
  • REVIEW: Sarah A Dabydeen and Priscilla A Furth
  • Genetically engineered ERα-positive breast cancer mouse models
  • Endocrine-Related Cancer 21 R195–R208 (June 2014)
  • REVIEW: Yevgeniya Kushchayeva, Kirk Jensen, Kenneth D Burman, and Vasyl Vasko
  • Repositioning therapy for thyroid cancer: new insights on established medications
  • Endocrine-Related Cancer 21 R183–R194 (June 2014)
  • REVIEW: Wen-Lung Ma, Hsueh-Chou Lai, Shuyuan Yeh, Xiujun Cai, and Chawnshang Chang
  • Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
  • Endocrine-Related Cancer 21 R165–R182 (June 2014)
  • REVIEW: M Fraenkel, M Kim, A Faggiano, W W de Herder, G D Valk, and On behalf of the Knowledge NETwork
  • Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature
  • Endocrine-Related Cancer 21 R153–R163 (June 2014)
  • REVIEW: Delila Gasi Tandefelt, Joost Boormans, Karin Hermans, and Jan Trapman
  • ETS fusion genes in prostate cancer
  • Endocrine-Related Cancer 21 R143–R152 (June 2014)
  • REVIEW: C R C Pieterman, E B Conemans, K M A Dreijerink, J M de Laat, H Th M Timmers, M R Vriens, and G D Valk
  • Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis
  • Endocrine-Related Cancer 21 R121–R142 (June 2014)
  • REVIEW: Louis de Mestier, Clarisse Dromain, Gaspard d'Assignies, Jean-Yves Scoazec, Nathalie Lassau, Rachida Lebtahi, Hedia Brixi, Emmanuel Mitry, Rosine Guimbaud, Frédéric Courbon, Michèèle d'Herbomez, and Guillaume Cadiot
  • Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art
  • Endocrine-Related Cancer 21 R105–R120 (June 2014)
  • REVIEW: Lucas Leite Cunha, Marjory Alana Marcello, and Laura Sterian Ward
  • The role of the inflammatory microenvironment in thyroid carcinogenesis
  • Endocrine-Related Cancer 21 R85–R103 (June 2014)
  • COMMENTARY: Frank Weber
  • Lymphocytes and thyroid cancer: more to it than meets the eye?
  • Endocrine-Related Cancer 21 C1–C5 (June 2014)
  • PROFILE: V Craig Jordan
  • 'Who do you think you are?'
  • Endocrine-Related Cancer 21 P13–P17 (June 2014)
  • PROFILE: Pat J Morin
  • Embracing change
  • Endocrine-Related Cancer 21 P9–P12 (June 2014)
  • PROFILE: Hartmut P H Neumann
  • My life for pheochromocytoma
  • Endocrine-Related Cancer 21 P1–P8 (June 2014)
  • THEMATIC REVIEW: Kazuyoshi Ukena, Tomohiro Osugi, Jérôme Leprince, Hubert Vaudry, and Kazuyoshi Tsutsui
  • MOLECULAR EVOLUTION OF GPCRS: 26Rfa/GPR103
  • Journal of Molecular Endocrinology 52 T119–T131 (June 2014)
  • THEMATIC REVIEW: Jérémy Pasquier, Nédia Kamech, Anne-Gaëlle Lafont, Hubert Vaudry, Karine Rousseau, and Sylvie Dufour
  • MOLECULAR EVOLUTION OF GPCRS: Kisspeptin/kisspeptin receptors
  • Journal of Molecular Endocrinology 52 T101–T117 (June 2014)
  • THEMATIC REVIEW: Hiroyuki Kaiya, Kenji Kangawa, and Mikiya Miyazato
  • MOLECULAR EVOLUTION OF GPCRS: Ghrelin/ghrelin receptors
  • Journal of Molecular Endocrinology 52 T87–T100 (June 2014)
  • THEMATIC REVIEW: Hervé Tostivint, Daniel Ocampo Daza, Christina A Bergqvist, Feng B Quan, Marion Bougerol, Isabelle Lihrmann, and Dan Larhammar
  • MOLECULAR EVOLUTION OF GPCRS: Somatostatin/urotensin II receptors
  • Journal of Molecular Endocrinology 52 T61–T86 (June 2014)
  • THEMATIC REVIEW: David A Lovejoy, Belinda S W Chang, Nathan R Lovejoy, and Jon del Castillo
  • MOLECULAR EVOLUTION OF GPCRS: CRH/CRH receptors
  • Journal of Molecular Endocrinology 52 T43–T60 (June 2014)
  • THEMATIC REVIEW: Robert M Dores, Richard L Londraville, Jeremy Prokop, Perry Davis, Nathan Dewey, and Natalie Lesinski
  • MOLECULAR EVOLUTION OF GPCRS: Melanocortin/melanocortin receptors
  • Journal of Molecular Endocrinology 52 T29–T42 (June 2014)
  • THEMATIC REVIEW: Jong-Ik Hwang, Seongsik Yun, Mi Jin Moon, Cho Rong Park, and Jae Young Seong
  • MOLECULAR EVOLUTION OF GPCRS: GLP1/GLP1 receptors
  • Journal of Molecular Endocrinology 52 T15–T27 (June 2014)
  • THEMATIC REVIEW: Janice K V Tam, Leo T O Lee, Jun Jin, and Billy K C Chow
  • MOLECULAR EVOLUTION OF GPCRS: Secretin/secretin receptors
  • Journal of Molecular Endocrinology 52 T1–T14 (June 2014)
  • EDITORIAL: Hubert Vaudry
  • MOLECULAR EVOLUTION OF GPCRS: What we know and what the future holds
  • Journal of Molecular Endocrinology 52 E1–E2 (June 2014)
  • REVIEW: Madhusmita Misra and Anne Klibansk
  • Anorexia nervosa and bone
  • Journal of Endocrinology 221 R163–R176 (June 2014)
  • REVIEW: Peter Smith, Dagmar Wilhelm, and Raymond J Rodgers
  • Development of mammalian ovary
  • Journal of Endocrinology 221 R145–R161 (June 2014)
  • REVIEW: Henrik Ortsäter, Nina Grankvist, Richard E Honkanen, and Åke Sjöholm
  • Protein phosphatases in pancreatic islets
  • Journal of Endocrinology 221 R121–R144 (June 2014)
  • REVIEW: Philip Newsholme, Vinicius Cruzat, Frank Arfuso, and Kevin Keane
  • Nutrient regulation of insulin secretion and action
  • Journal of Endocrinology 221 R105–R120 (June 2014)
  • REVIEW: A J Forhead and A L Fowden
  • Thyroid hormones in fetal growth and prepartum maturation
  • Journal of Endocrinology 221 R87–R103 (June 2014)
  • REVIEW: Karsten Suhre
  • Metabolic profiling in diabetes
  • Journal of Endocrinology 221 R75–R85 (June 2014)
  • REVIEW: R Prasad, J C Kowalczyk, E Meimaridou, H L Storr, and L A Metherell
  • Oxidative stress and adrenocortical insufficiency
  • Journal of Endocrinology 221 R63–R73 (June 2014)
  • REVIEW: Georgios A Christou and Dimitrios N Kiortsis
  • The role of adiponectin in renal physiology and development of albuminuria
  • Journal of Endocrinology 221 R49–R61 (May 2014)
  • REVIEW: Amy Hughes, Darling Rojas-Canales, Chris Drogemuller, Nicolas H Voelcker, Shane T Grey, and P T H Coates
  • IGF2: an endocrine hormone to improve islet transplant survival
  • Journal of Endocrinology 221 R41–R48 (May 2014)
  • REVIEW: Rodrigo S Fortunato, Andrea C F Ferreira, Fabio Hecht, Corinne Dupuy, and Denise P Carvalho
  • Sexual dimorphism and thyroid dysfunction: a matter of oxidative stress?
  • Journal of Endocrinology 221 R31–R40 (May 2014)
  • REVIEW: Laura D Brown
  • Endocrine regulation of fetal skeletal muscle growth: impact on future metabolic health
  • Journal of Endocrinology 221 R13–R29 (May 2014)
  • REVIEW: Rosalba Senese, Federica Cioffi, Pieter de Lange, Fernando Goglia, and Antonia Lanni
  • Thyroid: biological actions of 'nonclassical' thyroid hormones
  • Journal of Endocrinology 221 R1–R12 (May 2014)
  • THEMATIC REVIEW: Kevin C Knower, Sarah Q To, Yuet-Kin Leung, Shuk-Mei Ho, and Colin D Clyne
  • Endocrine disruption of the epigenome: a breast cancer link
  • Endocrine-Related Cancer 21 T33–T55 (April 2014)
  • THEMATIC REVIEW: Douglas A Gibson and Philippa T K Saunders
  • Endocrine disruption of oestrogen action and female reproductive tract cancers
  • Endocrine-Related Cancer 21 T13–T31 (April 2014)
  • THEMATIC REVIEW: Elizabeth Kopras, Veena Potluri, Mei-Ling Bermudez, Karin Williams, Scott Belcher, and Susan Kasper
  • Actions of endocrine-disrupting chemicals on stem/progenitor cells during development and disease
  • Endocrine-Related Cancer 21 T1–T12 (April 2014)
  • EDITORIAL: Gail P Risbridger
  • Are we disrupted?
  • Endocrine-Related Cancer 21 E1–E2 (April 2014)
  • REVIEW: Janne Lebeck
  • Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver
  • Journal of Molecular Endocrinology 52 R165–R178 (April 2014)
  • REVIEW: Andrea Weckman, Antonio Di Ieva, Fabio Rotondo, Luis V Syro, Leon D Ortiz, Kalman Kovacs, and Michael D Cusimano
  • Autophagy in the endocrine glands
  • Journal of Molecular Endocrinology 52 R151–R163 (April 2014)
  • REVIEW: Raffaella Maria Gadaleta and Luca Magnani
  • Nuclear receptors and chromatin: an inducible couple
  • Journal of Molecular Endocrinology 52 R137–R149 (April 2014)
  • REVIEW: Eva A Rog-Zielinska, Rachel V Richardson, Martin A Denvir, and Karen E Chapman
  • Glucocorticoids and foetal heart maturation; implications for prematurity and foetal programming
  • Journal of Molecular Endocrinology 52 R125–R135 (April 2014)
  • THEMATIC REVIEW: Benjamin J Lamont and Sofianos Andrikopoulos
  • Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology?
  • Journal of Endocrinology 221 T43–T61 (April 2014)
  • THEMATIC REVIEW: Christian Hölscher
  • Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
  • Journal of Endocrinology 221 T31–T41 (April 2014)
  • THEMATIC REVIEW: Franca S Angeli and Richard P Shannon
  • Incretin-based therapies: can we achieve glycemic control and cardioprotection?
  • Journal of Endocrinology 221 T17–T30 (April 2014)
  • THEMATIC REVIEW: L van Bloemendaal, J S ten Kulve, S E la Fleur, R G Ijzerman, and M Diamant
  • Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
  • Journal of Endocrinology 221 T1–T16 (April 2014)
  • EDITORIAL: Martin Haluzik
  • The expanding role of incretin-based therapies: how much should we expect?
  • Journal of Endocrinology 221 E1–E2 (April 2014)
  • REVIEW: Pouneh K Fazeli and Anne Klibanski
  • Determinants of GH resistance in malnutrition
  • Journal of Endocrinology 220 R57–R65 (March 2014)
  • REVIEW: Mathis Grossmann
  • Testosterone and glucose metabolism in men: current concepts and controversies
  • Journal of Endocrinology 220 R37–R55 (March 2014)
  • REVIEW: O Sukocheva and C Wadham
  • Role of sphingolipids in oestrogen signalling in breast cancer cells: an update
  • Journal of Endocrinology 220 R25–R35 (March 2014)
  • REVIEW: Giovanni Vitale, Germano Gaudenzi, Alessandra Dicitore, Franco Cotelli, Diego Ferone, and Luca Persani
  • Zebrafish as an innovative model for neuroendocrine tumors
  • Endocrine-Related Cancer 21 R67–R83 (February 2014)
  • REVIEW: Claudia Bozza, Fabio Puglisi, Matteo Lambertini, Etin-Osa Osa, Massimo Manno, and Lucia Del Mastro
  • Anti-Müllerian hormone: determination of ovarian reserve in early breast cancer patients
  • Endocrine-Related Cancer 21 R51–R65 (February 2014)
  • REVIEW: Kathleen Van Asten, Patrick Neven, Anneleen Lintermans, Hans Wildiers, and Robert Paridaens
  • Aromatase inhibitors in the breast cancer clinic: focus on exemestane
  • Endocrine-Related Cancer 21 R31–R49 (February 2014)
  • REVIEW: Federica Morani, Rossella Titone, Loredana Pagano, Alessandra Galetto, Oscar Alabiso, Gianluca Aimaretti, and Ciro Isidoro
  • Autophagy and thyroid carcinogenesis: genetic and epigenetic links
  • Endocrine-Related Cancer 21 R13–R29 (February 2014)
  • REVIEW: Ying Ying Sung and Edwin Cheung
  • Androgen receptor co-regulatory networks in castration-resistant prostate cancer
  • Endocrine-Related Cancer 21 R1–R11 (February 2014)
  • REVIEW: Viral Chikani and Ken K Y Ho
  • Action of GH on skeletal muscle function: molecular and metabolic mechanisms
  • Journal of Molecular Endocrinology 52 R107–R123 (February 2014)
  • REVIEW: Nelson D Horseman and Karen A Gregerson
  • Prolactin actions
  • Journal of Molecular Endocrinology 52 R95–R106 (February 2014)
  • REVIEW: A Stevens, C De Leonibus, D Hanson, A W Dowsey, A Whatmore, S Meyer, R P Donn, P Chatelain, I Banerjee, K E Cosgrove, P E Clayton, and M J Dunne
  • Network analysis: a new approach to study endocrine disorders
  • Journal of Molecular Endocrinology 52 R79–R93 (February 2014)
  • REVIEW: Erika Peverelli, Giovanna Mantovani, Andrea G Lania, and Anna Spada
  • cAMP in the pituitary: an old messenger for multiple signals
  • Journal of Molecular Endocrinology 52 R67–R77 (February 2014)
  • REVIEW: Custodia García-Jiménez, Jose Manuel García-Martínez, Ana Chocarro-Calvo, and Antonio De la Vieja
  • A new link between diabetes and cancer: enhanced WNT/& #946; -catenin signaling by high glucose
  • Journal of Molecular Endocrinology 52 R51–R66 (February 2014)
  • REVIEW: Nils Wierup, Frank Sundler, and R Scott Heller
  • The islet ghrelin cell
  • Journal of Molecular Endocrinology 52 R35–R49 (February 2014)
  • REVIEW: Adrien Georges, Aurelie Auguste, Laurianne Bessière, Anne Vanet, Anne-Laure Todeschini, and Reiner A Veitia
  • FOXL2: a central transcription factor of the ovary
  • Journal of Molecular Endocrinology 52 R17–R33 (February 2014)
  • REVIEW: Anthony H Tsang, Johanna L Barclay, and Henrik Oster
  • Interactions between endocrine and circadian systems
  • Journal of Molecular Endocrinology 52 R1–R16 (February 2014)
  • THEMATIC REVIEW: Nigel Turner, Gregory J Cooney, Edward W Kraegen, and Clinton R Bruce
  • Fatty acid metabolism, energy expenditure and insulin resistance in muscle
  • Journal of Endocrinology 220 T61–T79 (February 2014)
  • THEMATIC REVIEW: Haiming Cao
  • Adipocytokines in obesity and metabolic disease
  • Journal of Endocrinology 220 T47–T59 (February 2014)
  • THEMATIC REVIEW: Marc Schneeberger, Ramon Gomis, and Marc Claret
  • Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance
  • Journal of Endocrinology 220 T25–T46 (February 2014)
  • THEMATIC REVIEW: Shaodong Guo
  • Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms
  • Journal of Endocrinology 220 T1–T23 (February 2014)
  • EDITORIAL: Shaodong Guo
  • Decoding insulin resistance and metabolic syndrome for promising therapeutic intervention
  • Journal of Endocrinology 220 E1–E3 (February 2014)
  • REVIEW: Manuel D Gahete, David Rincon-Fernandez, Alicia Villa-Osaba, Daniel Hormaechea-Agulla, Alejandro Ibanez-Costa, Antonio J Martinez-Fuentes, Francisco Gracia-Navarro, Justo P Castano, and Raul M Luque
  • Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight
  • Journal of Endocrinology 220 R1–R24 (January 2014)